Tab. XXVIII.
Summary of probabilistic results.
| Hydrophilic | Uncoated | Incremental | |
|---|---|---|---|
| Average cost per patient (discounted) | € 75.267 | € 72.037 | € 3.230 |
| Average QALYs per patient (discounted) | 8.03 | 7.48 | 0.56 |
| Average incremental cost effectiveness ratio (ICER) | € 5.803 | ||
| Average net monetary benefit (NMB) per patient | € 7.902 | ||
| Probability of cost-effectiveness | 89.0% | ||